Inventor · disambiguated record
Zhenjian Du
Also filed as: DU ZHENJIAN
33 granted patents·9 pending applications·610 citations·filing 2004–2018
98Inventor score
Top patents by PatentIndex Score
42 records- 0198US8034834B2Method for treating proliferative disorders with HSP90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 11, 2011·53 cites·15 claims
- 0297US8648104B2Method for treating proliferative disorders associated with mutations in c-MetDU ZHENJIAN·Filed 2008·Granted Feb 11, 2014·38 cites·8 claims
- 0397US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0496US8415377B2Triazole compounds that modulate HSP90 activitySUN LIJUN·Filed 2011·Granted Apr 9, 2013·40 cites·19 claims
- 0596US8318790B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted Nov 27, 2012·49 cites·68 claims
- 0696US7825148B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Nov 2, 2010·53 cites·51 claims
- 0795US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 0895US7608635B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 27, 2009·32 cites·11 claims
- 0994US8629285B2Imidazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2006·Granted Jan 14, 2014·14 cites·17 claims
- 1094US8329736B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2012·Granted Dec 11, 2012·27 cites·14 claims
- 1194US8329899B2Pyrazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2011·Granted Dec 11, 2012·21 cites·12 claims
- 1294US8183384B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2007·Granted May 22, 2012·26 cites·16 claims
- 1394US7662813B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 16, 2010·35 cites·35 claims
- 1493US8362055B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·25 cites·20 claims
- 1591US8969396B2Method for treating a B-raf associated cancer with an Hsp90 inhibitorDU ZHENJIAN·Filed 2011·Granted Mar 3, 2015·7 cites·4 claims
- 1688US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 1788US8927548B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2012·Granted Jan 6, 2015·10 cites·9 claims
- 1887US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 1987US8921407B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Dec 30, 2014·7 cites·15 claims
- 2086US8901308B2Triazole compounds that modulate Hsp90 activityYING WEIWEN·Filed 2012·Granted Dec 2, 2014·7 cites·2 claims
- 2186US8524712B2Triazinone and diazinone derivatives useful as HSP90 inhibitorsLEE CHI-WAN·Filed 2008·Granted Sep 3, 2013·15 cites·8 claims
- 2286US7763658B2Treatment for cancersSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Jul 27, 2010·21 cites·6 claims
- 2385US9090569B2Triazone compounds that modulate HSP90 activityYING WEIWEN·Filed 2009·Granted Jul 28, 2015·5 cites·19 claims
- 2484US9108933B2Method for treating proliferative disorders associated with mutations in c-MetDU ZHENJIAN·Filed 2014·Granted Aug 18, 2015·3 cites·4 claims
- 2584US8993608B2Method for inhibiting topoisomerase IIDU ZHENJIAN·Filed 2008·Granted Mar 31, 2015·7 cites·13 claims
- 2682US9156794B2Imidazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Oct 13, 2015·4 cites·13 claims
- 2781US8269017B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2010·Granted Sep 18, 2012·4 cites·20 claims
- 2878US7884094B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 8, 2011·2 cites·8 claims
- 2970US2015094349A1Method for Treating Proliferative Disorders Associated with Protooncogene ProductsSYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 3068US2010069442A1Pyrazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3163US10047084B2Imidazolone derivatives, pharmaceutical compositions and uses thereofBEIJING FORELANDPHARMA CO LTD·Filed 2014·Granted Aug 14, 2018·2 cites·8 claims
- 3260US9090603B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Jul 28, 2015·0 cites·14 claims
- 3359US8598366B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2012·Granted Dec 3, 2013·0 cites·10 claims
- 3459US2009093538A1Method for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 3559US2015183771A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 3656US2016000756A1Imidazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 3753US2013072461A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 3849US2013345219A1Triazinone and diazinone derivatives useful as hsp90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2013·Application pending·0 cites
- 3941US2015174134A1Method for inhibiting topoisomerase iiSYNTA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 4038US2009042991A1Methods of increasing natural killer cell activity for therapyBARSOUM JAMES·Filed 2006·Application pending·0 cites
- 4130US11584726B2Amino alcohol derivative, pharmaceutical composition and application thereofBEIJING FORELAND PHARMA CO LTD·Filed 2018·Granted Feb 21, 2023·0 cites·11 claims
- 4226US10646483B2Crystal form of imidazolone type compounds, and preparation method, pharmaceutical composition and use thereofFORELAND PHARMA CO LTD·Filed 2016·Granted May 12, 2020·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Zhenjian Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →